Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPG.L Regulatory News (PPG)

  • There is currently no data for PPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Polyfect Soluti

10 Jul 2008 07:00

RNS Number : 7371Y
Ipso Ventures PLC
10 July 2008
 



SECOND LOUGHBOROUGH UNIVERSITY SPIN OUT

POLYFECT SOLUTIONS LIMITED

IPSO Ventures plc, the IP commercialisation specialist, is pleased to announce that its wholly owned subsidiary Ipso Management Limited ("IPSO") has created and invested in its second spin out company, Polyfect Solutions Limited ("Polyfect" or the "Company"), under its Framework Agreement with Loughborough University.

Polyfect, which has been spun-out from Loughborough University's Institute of Polymer Technology & Materials Engineering, has technology which demonstrates the ability both to reduce the cost of manufacturing plastic products and improve the quality of the plastic from which they are made.

The technology achieves savings and quality improvements through the highly efficient incorporation of functional fillers into plastics. Functional fillers are the materials which are used to change the properties of a plastic, for example, to make it non-static, to create gas barriers or change its pigmentation. Conventional processes for incorporating functional fillers in plastics achieve far from optimal results with a significant proportion of the material being poorly dispersed. This necessitates the use of large quantities of filler to achieve the desired properties. The fillers are typically more expensive than the virgin plastic and also degrade the mechanical properties of the plastic. Polyfect's technology allows significantly less filler to be used, resulting in both cost savings and quality improvements as well as having a positive environmental benefit. The process allows for a significant reduction in fillers such as carbon black. Polyfect's technology also improves filler dispersion within plastics by up to around 10 times that of conventional processes.

Polyfect's technology has the potential to enable the mass production of:

Cheaper plastics using smaller quantities of expensive functional fillers

Plastics with improved mechanical properties

New classes of materials with highly attractive properties

IPSO is investing up to £400,000 in two tranches. The Lachesis Fund, the University Challenge Fund for the East Midlands, is also involved in this transaction.

Polyfect will license this technology to operators in the plastics' supply chain for integration into their existing processes. Capital expenditure and running costs of using this technology are low whilst the potential material cost savings are high, making it profitable for licensees with a short payback time. Initial feedback from potential licensees on the technology has been very positive and IPSO believes that this business model should quickly generate high-margin royalty revenues for Polyfect. Initially, during scale-up, Polyfect will seek to work with a limited number of organisations that recognise the potential of the technology for their applications and wish to be amongst the first to realise its benefits.

Simon Hunt, Executive Chairman of IPSO, said: "We are very pleased to have created our second spin-out company under our agreement with Loughborough based upon a new process which enables a significant reduction in the cost of functional fillers in polymers. This process also has positive environmental benefits. We have assembled a strong team to take Polyfect forward and have appointed Ian Balchin as Interim CEO. Ian has over 20 years experience commercialising a wide range of technologies, including polymer related technologies. Amongst other achievements, he presided over a period of rapid growth during his time as president of Biotec Holdings GmbH, one of the largest manufacturers of biopolymers in Europe. We are also very pleased to have co-invested with the Lachesis fund."

Shirley Pearce, Vice-Chancellor, Loughborough University, added: "We are really excited about IPSO's second Loughborough spin out resulting from our partnership. We believe this is a further excellent example of how Loughborough enterprise can be translated by the right commercialisation partner from raw technology to the commercial market place. It is our second deal with IPSO in what is turning out to be a very positive relationship. The investment also includes the Lachesis fund with which the University has a long standing relationship."

Ian Balchin, CEO of Polyfect said, "Polyfect's technology has the potential to create significant savings for polymer processors through reduced filler costs, light-weighting of components and the creation of new polymer materials without having to use chemical processing to ensure good dispersion of fillers. In particular, at a time when high oil prices are impacting on polymer feedstock prices, Polyfect's technology should be welcomed as a way of reducing manufacturing costs and environmental impact. My initial focus will be on scaling up the technology and engaging with a select number of organisations that recognise its potential and wish to be amongst the first to realise its benefits."

 

Further information, please contact:

IPSO Ventures plc: Tel: 020 7395 1500 

Simon Hunt, Chairman simon@ipsoventures.com

Nick Rodgers, Chief Executive  nick@ipsoventures.com

www.ipsoventures.com

Ambrian Partners Limited Tel: 020 7776 6421

Tim Goodman tim.goodman@ambrian.com

Rawlings Financial PR Limited Tel: 01653 618 016

Catriona Valentine catriona@rawlingsfinancial.co.uk

www.rawlingsfinancial.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZGGGNVLZGRZM
Date   Source Headline
20th Sep 20211:00 pmRNSUpdate
23rd Aug 20214:30 pmRNSUpdate re: Nominated Adviser
20th Aug 20212:00 pmRNSUpdate re: Nominated Adviser
11th Jun 20217:30 amRNSSuspension - Plutus Powergen plc
11th Jun 20217:00 amRNSProposed Reverse Takeover & Suspension of Trading
19th May 20214:18 pmRNSResult of AGM
22nd Apr 20214:09 pmRNSNotice of AGM
8th Mar 202111:17 amRNSHolding(s) in Company
5th Feb 202111:03 amRNSHalf-year Report
29th Jan 20215:09 pmRNSFinal Results
28th Jan 20217:00 amRNSConvertible loan note
8th Jan 20212:58 pmRNSStatement re share price movement
8th Jan 20217:00 amRNSAppointment of Joint Broker
31st Dec 20201:00 pmRNSTotal Voting Rights
10th Dec 20209:30 amRNSDemerger, Admission of Shares & AIM Rule 15 status
4th Dec 202010:00 amRNSReduction of Capital effective
24th Nov 20205:42 pmRNSReduction of Capital approved by the Court
19th Nov 20206:15 pmRNSPlutus Powergen
6th Nov 202011:00 amRNSFurther re Capital Reorganisation
3rd Nov 202011:59 amRNSResult of General Meeting & Further re Demerger
9th Oct 20204:28 pmRNSProposed demerger, placing, notice of GM & update
29th Jun 20207:00 amRNSNew Website Address
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
3rd Apr 202011:26 amRNSHolding(s) in Company
1st Apr 20207:00 amRNSCorporate Update
29th Jan 20207:00 amRNSInterim Results
27th Jan 202010:24 amRNSHolding(s) in Company
22nd Jan 20207:00 amRNSLoan agreement and related party transaction
10th Jan 202012:50 pmRNSResult of General Meeting
10th Jan 202010:59 amRNSResult of AGM
13th Dec 20197:00 amRNSNotice of GM & AGM
21st Nov 20191:29 pmRNSRequisition of General Meeting
19th Nov 20197:00 amRNSOperational and financial update
13th Nov 20195:05 pmRNSReceipt of purported notice of requisition of GM
12th Nov 20194:04 pmRNSDirector holdings & Update on Director Dealings
31st Oct 20196:38 pmRNSFinal Results
30th Oct 20197:00 amRNSBoard update
25th Oct 201911:28 amRNSStatement on Capacity Market EC ruling
21st Oct 20197:00 amRNSBoard update
3rd Sep 20192:02 pmRNSUpdate re Planning Permission Application
29th Aug 20197:00 amRNSAgreement for Gas Site Funding and Rockpool update
12th Aug 20197:00 amRNSSupport to UK National Grid in latest power crisis
31st Jul 20195:00 pmRNSTotal Voting Rights
31st Jul 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20194:00 pmRNSHolding(s) in Company
24th Jul 20195:23 pmRNSHolding(s) in Company
18th Jul 20196:00 pmRNSUpdate on Issue of Equity
16th Jul 20197:00 amRNSIssue of Equity
27th Jun 20192:01 pmRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.